Medicare Enrolled

Dr. Luke Schlesier, PHYSICIAN ASSISTANT

Physician Assistant · Flemington, NJ
Low-engagement
2100 WESCOTT DR, Flemington, NJ 08822
9087886461
In practice since 2007 (18 years)
NPI: 1194915751 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schlesier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schlesier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schlesier

Dr. Luke Schlesier is a physician assistant in Flemington, NJ, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Schlesier received a total of $3,891 from 62 pharmaceutical and/or device companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schlesier is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $3,891 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,891
Total received (2021-2024)
Avg $973/year across 4 years
Top 7% in NJ for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,817 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,690
2023
$1,102
2022
$600
2021
$498

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$205
Novartis Pharmaceuticals Corporation
$140
Takeda Pharmaceuticals U.S.A., Inc.
$114
Daiichi Sankyo Inc.
$95
AstraZeneca Pharmaceuticals LP
$93
Eisai Inc.
$71
Genentech USA, Inc.
$70
Janssen Biotech, Inc.
$66
Genmab U.S., Inc.
$57
Janssen Pharmaceuticals, Inc
$57
Lilly USA, LLC
$57
Tempus AI, Inc
$53
GlaxoSmithKline, LLC.
$50
Incyte Corporation
$48
Bayer Healthcare Pharmaceuticals Inc.
$47
Ipsen Biopharmaceuticals, Inc
$36
Regeneron Healthcare Solutions, Inc.
$34
Aveo Pharmaceuticals, Inc.
$32
Cumberland Pharmaceuticals, Inc.
$30
Rigel Pharmaceuticals, Inc.
$26
TAIHO ONCOLOGY, INC.
$21
Alexion Pharmaceuticals, Inc.
$19
Celltrion USA Inc.
$19
BeiGene USA, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
SOBI, INC
$18
Fresenius Kabi USA, LLC
$17
Celgene Corporation
$17
Mirati Therapeutics, Inc.
$17
Karyopharm Therapeutics Inc.
$17
EMD Serono, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
SERVIER PHARMACEUTICALS LLC
$17
TerSera Therapeutics LLC
$17
Adaptive Biotechnologies Corporation
$17
Stemline Therapeutics Inc.
$15
Blueprint Medicines Corporation
$15
ADC Therapeutics America, Inc.
$15
Top 3 companies account for 27.1% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$351
Novartis Pharmaceuticals Corporation
$331
ABBVIE INC.
$264
Eisai Inc.
$188
Takeda Pharmaceuticals U.S.A., Inc.
$164
Daiichi Sankyo Inc.
$160
Regeneron Healthcare Solutions, Inc.
$149
Incyte Corporation
$147
Seagen Inc.
$137
AstraZeneca Pharmaceuticals LP
$127
Lilly USA, LLC
$97
Genmab U.S., Inc.
$74
Janssen Pharmaceuticals, Inc
$72
Genentech USA, Inc.
$70
MorphoSys, US Inc.
$68
Amgen Inc.
$66
GlaxoSmithKline, LLC.
$63
Celgene Corporation
$61
E.R. Squibb & Sons, L.L.C.
$57
GE HEALTHCARE
$56
TAIHO ONCOLOGY, INC.
$56
TerSera Therapeutics LLC
$55
Tempus AI, Inc
$53
Mirati Therapeutics, Inc.
$50
Ipsen Biopharmaceuticals, Inc
$49
EMD Serono, Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$47
Dendreon Pharmaceuticals LLC
$46
Fresenius Kabi USA, LLC
$43
Acrotech Biopharma Inc.
$39
SERVIER PHARMACEUTICALS LLC
$37
BeiGene USA, Inc.
$36
Pharmacyclics LLC, an AbbVie Company
$33
Aveo Pharmaceuticals, Inc.
$32
Kyowa Kirin, Inc.
$31
Pharmacyclics LLC, An AbbVie Company
$31
Cumberland Pharmaceuticals, Inc.
$30
Blueprint Medicines Corporation
$30
PFIZER INC.
$29
Stemline Therapeutics Inc.
$28
Myovant Sciences Inc.
$28
EISAI INC.
$28
Rigel Pharmaceuticals, Inc.
$26
Heron Therapeutics, Inc.
$24
Alexion Pharmaceuticals, Inc.
$19
Celltrion USA Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
SOBI, INC
$18
Karyopharm Therapeutics Inc.
$17
Adaptive Biotechnologies Corporation
$17
Servier Pharmaceuticals LLC
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Sobi, Inc
$15
ADC Therapeutics America, Inc.
$15
AVEO Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
GENZYME CORPORATION
$14
Apellis Pharmaceuticals, Inc.
$14
Taiho Oncology, Inc.
$14
AbbVie Inc.
$13
Octapharma USA, Inc.
$12
Janssen Scientific Affairs, LLC
$11
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BELEODAQ · BRUKINSA · Blincyto · CALQUENCE · CYRAMZA · Columvi · DARZALEX · DOPTELET · ELAHERE · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROVENGE · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Rezlidhia · SANCUSO · SCEMBLIX · SKYRIZI · SUSTOL · SYNAGIS · Somatuline Depot · Stimufend · Stivarga · TALVEY · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · TZIELD · Tecentriq · Tibsovo · Tivdak · ULTOMIRIS · VEGZELMA · VENCLEXTA · VERZENIO · Venclexta · Voranigo · XALKORI · XARELTO · XPOVIO · XT CDX · Xermelo · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for physician assistant in NJ.

Looking for a physician assistant in Flemington?
Compare physician assistants in the Flemington area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
707
Per 100K population
546.2
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schlesier is a physician assistant, with low-engagement industry engagement in the top 7% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Schlesier receive payments from pharmaceutical companies?
Yes. Dr. Schlesier received a total of $3,891 from 62 companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Schlesier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →